The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Sat., Aug. 17, 10:32 AM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #11. Alliqua Choice Therapeutics

Acquirer: Alliqua (NASDAQ:ALQA)
Acquiree: Choice Therapeutics
Details: Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or the "Company"), a provider of advanced wound care products, has acquired Choice Therapeutics, Inc. ("Choice Therapeutics"), a privately held wound care company with proprietary technologies and products, for approximately $4 million in stock and cash. The merger agreement, which became effective May 5, 2014, provides for additional contingent payments of up to $5 million in stock or cash, under certain circumstances, if stated revenue thresholds are reached over the next three years ending April 30, 2017. The acquisition is expected to be accretive to Alliqua's earnings during the next 12 months.

Adynxx is a technologies company that commercializes differentiated regenerative medical products which assist the body in the repair of human tissue. Co.'s subsidiary, Celleration, Inc. developed the MIST® Ultrasound Healing Therapy (MIST Therapy) therapeutic ultrasound platform for the treatment of acute and chronic wounds. MIST Therapy is a noncontact, low-frequency ultrasound delivered through a saline mist to the wound bed. Co. has a license in intellectual property related to certain placental based products for wound care and wound management, including those made from extracellular matrix derived from the human placenta, and Biovance® Amniotic Membrane Allograft.

Open the ALQA Page at The Online Investor »

Company Name: 
Adynxx Inc
Website: 
www.alliqua.com
Sector: 
Medical Instruments & Supplies
 

Open the ALQA Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 11 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.